Aug. 22, 2012 (China Knowledge) - Shanghai
Pharmaceuticals Holding Co Ltd<601607><2607>, has announced its net profit for the first half of this year to decrease 14.52% YoY to RMB 1.15 billion, according to a statement filed with Shanghai Stock Exchange.
Basic earnings per share for the six-month period were RMB 0.43, 31.78% lower than in the corresponding period of 2011.
From January to June, the Shanghai
and Hong Kong-listed
firm's operating revenue surged 30.02% YoY to RMB 33.62 billion.
Revenue from its medicine distribution business grew 34.9% from a year earlier to RMB 28.83 billion in the period, while that from medicine retail business reached RMB 1.32 billion, reflecting a YoY increase of 23.88%.